SEP 10, 2020 11:12 AM PDT

Common Painkiller Increases Risk-Taking Behavior

WRITTEN BY: Annie Lennon

Researchers from Ohio State University have found that the common painkiller, paracetamol ( also known as Tylenol and Panadol), may increase risk-taking behaviors in people who take it. 

For the study, the researchers recruited over 500 university students. They then selected them at random to receive either a 1,000 mg dose of paracetamol (the maximum recommended single dosage for adults) or a placebo. 

Afterward, the students were asked to inflate a balloon using a pump on a computer screen, with each extra pump earning virtual money. They were instructed to earn as much money as possible, and as such, inflate the balloons as much as possible. Would the balloon pop, however, they were told that they would lose the money. 

In the end, the researchers found that students who took a dose of paracetamol tended to be more risk-taking during the exercise, pumping the balloon more actively than those in the placebo group. As such, they were also more likely to burst their balloons than those on the placebo. 

Aside from the balloon experiment, the participants also filled in surveys rating their level of perceived risk in various scenarios, such as betting a day's income on a sporting event or driving a car without a seatbelt. While paracetamol consumption seemed to influence risk perception in one survey, in another, it seemed to have little effect. 

Despite this, taking all the results into account together, the researchers concluded that paracetamol consumption could lead to more risk-taking behavior, likely by reducing levels of anxiety. As such, they say that public health officials should bear the drug's effect on behavior in mind before making health recommendations.

"Perhaps someone with mild COVID-19 symptoms may not think it is as risky to leave their house and meet with people if they're taking acetaminophen," says Baldwin Way, lead author of the study. "We really need more research on the effects of acetaminophen and other over-the-counter drugs on the choices and risks we take."

 

Sources: Oxford AcademicScience AlertOhio State News

 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
NOV 02, 2020
Immunology
New Cancer Drug Reboots Stalled Immunotherapies
NOV 02, 2020
New Cancer Drug Reboots Stalled Immunotherapies
In contrast to traditional chemotherapies, immunotherapies reprogram the patient’s own immune system to fight tumo ...
NOV 18, 2020
Technology
Using Machine Learning to Build Chemical Libraries
NOV 18, 2020
Using Machine Learning to Build Chemical Libraries
Using machine learning in drug discovery is no longer a novel procedure and has been well documented in recent literatur ...
NOV 26, 2020
Drug Discovery & Development
Sestrin Increases the Lifespan of Fruit Flies
NOV 26, 2020
Sestrin Increases the Lifespan of Fruit Flies
Reduced food intake, known as dietary restriction, leads to a longer lifespan in many animals and can improve health in ...
DEC 01, 2020
Immunology
Scar-Free Healing Starts With Mobilizing the Immune System
DEC 01, 2020
Scar-Free Healing Starts With Mobilizing the Immune System
Thanks to a new hydrogel biomaterial developed by researchers at Duke University, we are one step closer to the holy gra ...
DEC 08, 2020
Immunology
Drug Targets Cold Tumors' Achilles Heel
DEC 08, 2020
Drug Targets Cold Tumors' Achilles Heel
Immunotherapies have emerged as a powerful treatment modality for cancer. They join chemotherapy, surgery, radiotherapy, ...
JAN 18, 2021
Immunology
Arthritis Drug Approved for Critically Ill COVID Patients
JAN 18, 2021
Arthritis Drug Approved for Critically Ill COVID Patients
Critically ill COVID patients in the U.K. may receive an arthritis drug after a study showed that treatment lowered mort ...
Loading Comments...